SLC39A13 and ovarian cancer: In ovarian cancer, SLC39A13 (ZIP13) and ZIP5, ZIP10, ZIP12 and ZIP14 overexpression were found to be associated with poor prognosis, and SLC39A13 knockout demonstrated suppression of the malignant phenotype in vitro and in vivo and a higher vesicular zinc level in knockout cells [127].